|
1
|
Quintás-Cardama A and Cortes JE: Chronic
myeloid leukemia: Diagnosis and treatment. Mayo Clin Proc.
81:973–988. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
Quintás-Cardama A and Cortes JE: Molecular
biology of bcr-abl1-positive chronic myeloid leukemia. Blood.
113:1619–1630. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Perrotti D, Jamieson C, Goldman J and
Skorski T: Chronic myeloid leukemia: Mechanisms of blastic
transformation. J Clin Invest. 120:2254–2264. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yang HS, Cho MH, Zakowicz H, Hegamyer G,
Sonenberg N and Colburn NH: A novel function of the MA-3 domains in
transformation and translation suppressor Pdcd4 is essential for
its binding to eukaryotic translation initiation factor 4A. Mol
Cell Biol. 24:3894–3906. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Singh P, Wedeken L, Waters LC, Carr MD and
Klempnauer KH: Pdcd4 directly binds the coding region of c-myb mRNA
and suppresses its translation. Oncogene. 30:4864–4873. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Biyanee A, Ohnheiser J, Singh P and
Klempnauer KH: A novel mechanism for the control of translation of
specific mRNAs by tumor suppressor protein Pdcd4: Inhibition of
translation elongation. Oncogene. 34:1384–1392. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hilliard A, Hilliard B, Zheng SJ, Sun H,
Miwa T, Song W, Göke R and Chen YH: Translational regulation of
autoimmune inflammation and lymphoma genesis by programmed cell
death 4. J Immunol. 177:8095–8102. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Jansen AP, Camalier CE and Colburn NH:
Epidermal expression of the translation inhibitor programmed cell
death 4 suppresses tumorigenesis. Cancer Res. 65:6034–6041. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chen Y, Knösel T, Kristiansen G, Pietas A,
Garber ME, Matsuhashi S, Ozaki I and Petersen I: Loss of PDCD4
expression in human lung cancer correlates with tumour progression
and prognosis. J Pathol. 200:640–646. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang H, Ozaki I, Mizuta T, Hamajima H,
Yasutake T, Eguchi Y, Ideguchi H, Yamamoto K and Matsuhashi S:
Involvement of programmed cell death 4 in transforming growth
factor-beta1-induced apoptosis in human hepatocellular carcinoma.
Oncogene. 25:6101–6112. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Mudduluru G, Medved F, Grobholz R, Jost C,
Gruber A, Leupold JH, Post S, Jansen A, Colburn NH and Allgayer H:
Loss of programmed cell death 4 expression marks adenoma-carcinoma
transition, correlates inversely with phosphorylated protein kinase
B, and is an independent prognostic factor in resected colorectal
cancer. Cancer. 110:1697–1707. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wei ZT, Zhang X, Wang XY, Gao F, Zhou CJ,
Zhu FL, Wang Q, Gao Q, Ma CH, Sun WS, et al: PDCD4 inhibits the
malignant phenotype of ovarian cancer cells. Cancer Sci.
100:1408–1413. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Gao F, Zhang P, Zhou C, Li J, Wang Q, Zhu
F, Ma C, Sun W and Zhang L: Frequent loss of PDCD4 expression in
human glioma: Possible role in the tumorigenesis of glioma. Oncol
Rep. 17:123–128. 2007.PubMed/NCBI
|
|
14
|
Yang HS, Knies JL, Stark C and Colburn NH:
Pdcd4 suppresses tumor phenotype in JB6 cells by inhibiting AP-1
transactivation. Oncogene. 22:3712–3720. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yang HS, Matthews CP, Clair T, Wang Q,
Baker AR, Li CC, Tan TH and Colburn NH: Tumorigenesis suppressor
Pdcd4 down-regulates mitogen-activated protein kinase kinase kinase
kinase 1 expression to suppress colon carcinoma cell invasion. Mol
Cell Biol. 26:1297–1306. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Leupold JH, Yang HS, Colburn NH, Asangani
I, Post S and Allgayer H: Tumor suppressor Pdcd4 inhibits
invasion/intravasation and regulates urokinase receptor (u-PAR)
gene expression via Sp-transcription factors. Oncogene.
26:4550–4562. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang Q, Sun Z and Yang HS: Downregulation
of tumor suppressor Pdcd4 promotes invasion and activates both
beta-catenin/Tcf and AP-1-dependent transcription in colon
carcinoma cells. Oncogene. 27:1527–1535. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang Q, Sun ZX, Allgayer H and Yang HS:
Downregulation of E-cadherin is an essential event in activating
beta-catenin/Tcf-dependent transcription and expression of its
target genes in Pdcd4 knockdown cells. Oncogene. 29:128–138. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Vardiman JW, Harris NL and Brunning RD:
The World Health Organization (WHO) classification of the myeloid
neoplasms. Blood. 100:2292–2302. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Neviani P, Santhanam R, Trotta R, Notari
M, Blaser BW, Liu S, Mao H, Chang JS, Galietta A, Uttam A, et al:
The tumor suppressor PP2A is functionally inactivated in blast
crisis CML through the inhibitory activity of the BCR/ABL-regulated
SET protein. Cancer Cell. 8:355–368. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Beck Z, Kiss A, Tóth FD, Szabó J, Bácsi A,
Balogh E, Borbély A, Telek B, Kovács E, Oláh E and Rak K:
Alterations of P53 and RB genes and the evolution of the
accelerated phase of chronic myeloid leukemia. Leuk Lymphoma.
38:587–597. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Peng C, Chen Y, Yang Z, Zhang H, Osterby
L, Rosmarin AG and Li S: PTEN is a tumor suppressor in CML stem
cells and BCR-ABL-induced leukemias in mice. Blood. 115:626–635.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Riccioni R, Lulli V, Castelli G, Biffoni
M, Tiberio R, Pelosi E, LoCoco F and Testa U: miR-21 is
overexpressed in NPM1-mutant acute myeloid leukemias. Leuk Res.
39:221–228. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Song X, Zhang X, Wang X, Zhu F, Guo C,
Wang Q, Shi Y, Wang J, Chen Y and Zhang L: Tumor suppressor gene
PDCD4 negatively regulates autophagy by inhibiting the expression
of autophagy-related gene ATG5. Autophagy. 9:743–755. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ozpolat B, Akar U, Steiner M,
ZorrillaCalancha I, TiradoGomez M, Colburn N, Danilenko M, Kornblau
S and Berestein GL: Programmed cell death-4 tumor suppressor
protein contributes to retinoic acid-induced terminal granulocytic
differentiation of human myeloid leukemia cells. Mol Cancer Res.
5:95–108. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Cash AC and Andrews J: Fine scale analysis
of gene expression in Drosophila melanogaster gonads reveals
Programmed cell death 4 promotes the differentiation of female
germline stem cells. BMC Dev Biol. 12:42012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhou M, Zeng J, Wang X, Wang X, Huang T,
Fu Y, Sun T, Jia J and Chen C: Histone demethylase RBP2 decreases
miR-21 in blast crisis of chronic myeloid leukemia. Oncotarget.
6:1249–1261. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Cilloni D and Saglio G: Molecular
pathways: BCR-ABL. Clin Cancer Res. 18:930–937. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Parmar S, Smith J, Sassano A, Uddin S,
Katsoulidis E, Majchrzak B, Kambhampati S, Eklund EA, Tallman MS,
Fish EN and Platanias LC: Differential regulation of the p70 S6
kinase pathway by interferon alpha (IFNalpha) and imatinib mesylate
(STI571) in chronic myelogenous leukemia cells. Blood.
106:2436–2443. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Carayol N, Katsoulidis E, Sassano A,
Altman JK, Druker BJ and Platanias LC: Suppression of programmed
cell death 4 (PDCD4) protein expression by BCR-ABL-regulated
engagement of themTOR/p70 S6 kinase pathway. J Biol Chem.
283:8601–8610. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Woodard J, Sassano A, Hay N and Platanias
LC: Statin-dependent suppression of the Akt/mammalian target of
rapamycin signaling cascade and programmed cell death 4
up-regulation in renal cell carcinoma. Clin Cancer Res.
14:4640–4649. 2008. View Article : Google Scholar : PubMed/NCBI
|
